Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 044488/0116 | |
| Pages: | 59 |
| | Recorded: | 11/20/2017 | | |
| Attorney Dkt #: | 51008-008002 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/01/2019
|
Application #:
|
15637365
|
Filing Dt:
|
06/29/2017
|
|
Publication #:
|
|
Pub Dt:
|
10/19/2017
| | | | |
|
Title:
|
1 -(5-TERT-BUTYL-2-ARYL-PYRAZOL-3-YL)-3-[2-FLUORO-4-[(3-OXO-4H-PYRIDO[2, 3-B]PYRAZIN-8-YL)OXY]PHENYL]UREA DERIVATIVES AS RAF INHIBITORS FOR THE TREATMENT OF CANCER
|
|
|
Assignees
|
|
|
|
|
| ANGEL BUILDING |
| 407 ST JOHN STREET |
| LONDON, UNITED KINGDOM EC1V 4AD |
|
|
|
|
|
| 123 OLD BROMPTON ROAD |
| LONDON, UNITED KINGDOM SW7 3RP |
|
|
Correspondence name and address
|
| |
CLARK & ELBING LLP
|
| |
101 FEDERAL STREET
|
| |
15TH FLOOR
|
| |
BOSTON, MA 02110
|
Search Results as of:
06/06/2024 05:49 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
